Skip to main content
AAN.com
Editorial
October 10, 2000
editorial

What causes intracerebral hemorrhage during warfarin therapy?

October 10, 2000 issue
55 (7) 907-908

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Rosand J, Hylek EM, O’Donnell HC, Greenberg SM. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology . 2000; 55: 947–951.
2.
Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med . 1994; 120: 897–902.
3.
Stroke Prevention in Reversible Ischemia Trial Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol . 1997; 42: 857–865.
4.
Hart RG, Boop BS, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke . 1995; 26: 1471–1477.
5.
Gorter JW. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention in Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology . 1999, 53: 1319–1327.
6.
Hart RG, Halperin JL, McBride R, Benavente O, Man-Son-Hing M, Kronmal RA. Aspirin for the primary prevention of stroke and other major vascular events. Arch Neurol . 2000; 57: 326–332.
7.
He J, Whelton RK, Vu B, Klag MJ. Aspirin and risk of hemorrhagic stroke. JAMA . 1998; 280: 1930–1935.
8.
Roob G, Schmidt R, Kapellar P, Lechner A, Hartung HP, Fazekas F. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology . 1999; 52: 991–994.
9.
Greenberg SM, O’Donnell HC, Schaefer PW, Kraft E. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology . 1999; 53: 1135–1138.

Information & Authors

Information

Published In

Neurology®
Volume 55Number 7October 10, 2000
Pages: 907-908
PubMed: 11061242

Publication History

Published online: October 10, 2000
Published in print: October 10, 2000

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Robert G. Hart, MD
From the Department of Medicine, University of Texas Health Science Center, San Antonio.

Notes

Address correspondence to Dr. Robert G. Hart, Professor of Medicine (Neurology), University of Texas Health Science Center, MSC: 7883, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline 2022, Physical Therapy, 102, 8, (2022).https://doi.org/10.1093/ptj/pzac057
    Crossref
  2. Neurological Complications of Anticoagulation, Transfusion Practice in Clinical Neurosciences, (549-560), (2022).https://doi.org/10.1007/978-981-19-0954-2_46
    Crossref
  3. Small vessel disease burden and intracerebral haemorrhage in patients taking oral anticoagulants, Journal of Neurology, Neurosurgery & Psychiatry, 92, 8, (805-814), (2021).https://doi.org/10.1136/jnnp-2020-325299
    Crossref
  4. Other Neurological Conditions and Age-Related Changes, Geriatric Forensic Medicine and Pathology, (310-320), (2020).https://doi.org/10.1017/9781316823040.020
    Crossref
  5. Anticoagulant-associated intracerebral hemorrhage, Brain Hemorrhages, 1, 1, (89-94), (2020).https://doi.org/10.1016/j.hest.2020.01.001
    Crossref
  6. Hemorrhagic Strokes, Posterior Circulation Stroke, (121-133), (2020).https://doi.org/10.1007/978-981-15-6739-1_8
    Crossref
  7. Intracerebral hemorrhage: an update on diagnosis and treatment, Expert Review of Neurotherapeutics, 19, 7, (679-694), (2019).https://doi.org/10.1080/14737175.2019.1623671
    Crossref
  8. WITHDRAWN: Anticoagulant-associated intracerebral hemorrhage, Hemorrhagic Stroke, (2019).https://doi.org/10.1016/j.hest.2019.06.001
    Crossref
  9. The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?, Clinical Pharmacology & Therapeutics, 106, 2, (338-349), (2019).https://doi.org/10.1002/cpt.1491
    Crossref
  10. Ventricular Assist Device Patients Have Different Clinical Outcomes and Altered Patterns of Bleeding with Intracranial Hemorrhage, ASAIO Journal, 64, 4, (e55-e60), (2018).https://doi.org/10.1097/MAT.0000000000000744
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share